Carrie L. Cummings

Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation

Paula G. Heller, Ana C. Glembotsky, Manish J. Gandhi et al. · Blood · 2005 · 100 citations

Life Sciences, Genetics, Hematology +17

The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells

Vivian G. Oehler, Katherine A. Guthrie, Carrie L. Cummings et al. · Blood · 2009 · 83 citations · Full text

Medicine, Cancer Biology, Oncology +14

Comprehensive Transcriptome Profiling of Cryptic <i>CBFA2T3–GLIS2</i> Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Jenny L. Smith, Rhonda E. Ries, Tiffany Hylkema et al. · Clinical Cancer Research · 2019 · 76 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +14

&lt;i&gt;FLJ14813&lt;/i&gt; Missense Mutation: A Candidate for Autosomal Dominant Thrombocytopenia on Human Chromosome 10

Manish J. Gandhi, Carrie L. Cummings, Jonathan G. Drachman · Human Heredity · 2003 · 58 citations

Life Sciences, Genetics, Molecular Genetics +13

Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets

Valerie Morris, Carrie L. Cummings, Brendan Korb et al. · Molecular and Cellular Biology · 2015 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17